Abstract: Provided is a constant force pump accommodating syringes of different sizes. The system is provided by an enclosure having a base having a proximal end and a distal end, the base structured and arranged to receive a syringe having a plunger slidably disposed within a chamber having an outlet, the chamber having a length and a diameter, the plunger having a head; a pusher in sliding engagement with the base, the pusher structured and arranged to contact the head of the plunger; a puller in sliding engagement with the base; a sizer structured and arranged to determine the size of the chamber; an adjustable driver structured and arranged to provide a constant force between the pusher and the puller, the constant force adjustably selected by the size of the chamber. An associated method of use is provided as well.

Abstract: Provided is a butterfly needle assembly, including: a flexible member having a central region with a first side member and a second side member collectively providing a generally flat bottom, the central region having a middle area; an adhesive dressing disposed upon the generally flat bottom, the adhesive dressing protected by a removable cover; a needle hub disposed within the central region, the needle hub receiving a flexible tubing line generally parallel to the generally flat bottom and providing a needle extending generally normal to the generally flat bottom from the middle area of the central region, the needle extending for a first length; a removable needle cover initially disposed about the needle, the removable needle cover structured and arranged to removably engage with the needle hub; and a closing system structured and arranged to close the first side member and the second side member of the flexible member about the needle. A method of making a butterfly needle assembly is also provided.

Abstract: There is provided a perovskite material A perovskite material having the formula (I): AaA?bA?cSn(y)Pb(1-y)X3 (I) wherein A consists of a monovalent cation; A? consists of a monovalent organic cation having an ionic radius greater than 2.53 ?; A? consists of a monovalent inorganic cation; X comprises one or more halide anions; 0<a<1; 0<b<1; 0?c<1; a+b+c=1; and 0<y<1. Also provided is a semiconductor device having a photoactive region comprising a perovskite material as defined herein; a semiconductor device which is a photovoltaic device; and a multijunction photovoltaic device comprising two or more sub-cells, wherein the first sub cell comprises a photovoltaic device as defined herein and a further sub-cell comprising a photoactive layer having a bandgap of between 1.5 and 1.9 eV.

Abstract: There is provided a multi-junction photovoltaic device comprising a first sub-cell disposed over a second sub-cell, the first sub-cell comprising a photoactive region comprising a layer of perovskite material and the second sub-cell comprising a silicon heterojunction (SHJ).

Abstract: Compositions comprising a population of oligodendrocyte progenitor cells (OPCs), as well as methods of making and using the same, are provided. In one aspect, a container comprising a composition, where the composition comprises a population of cells comprising a plurality of OPCs, and where the population of cells comprises less than 15% undesirable cell types is provided. In another aspect, the population of cells comprises less than 15% undesirable epithelial lineage cells. In yet another aspect, the population of cells comprises less than 2% K7 positive cells. In an aspect, a population of cells comprising a plurality of oligodendrocyte progenitor cells is capable of forming less than one epithelial cyst per 100,000 cells in a cyst assay is provided. An even further aspect of the present disclosure is a container comprising a composition, where the composition comprising a plurality of oligodendrocyte progenitor cells is useful in treating treat stroke, spinal cord injury, and multiple sclerosis.

Abstract: Compositions comprising a population of oligodendrocyte progenitor cells (OPCs), as well as methods of making and using the same, are provided. In one aspect, a container comprising a composition, where the composition comprises a population of cells comprising a plurality of OPCs, and where the population of cells comprises less than 15% undesirable cell types is provided. In another aspect, the population of cells comprises less than 15% undesirable epithelial lineage cells. In yet another aspect, the population of cells comprises less than 2% K7 positive cells. In an aspect, a population of cells comprising a plurality of oligodendrocyte progenitor cells is capable of forming less than one epithelial cyst per 100,000 cells in a cyst assay is provided. An even further aspect of the present disclosure is a container comprising a composition, where the composition comprising a plurality of oligodendrocyte progenitor cells is useful in treating treat stroke, spinal cord injury, and multiple sclerosis.

Abstract: A multi-junction photovoltaic device comprising a layer of metal oxynitride between a first sub-cell and a second sub-cell is disclosed, the first sub-cell having a layer comprising a perovskite light absorber material. In addition, a method of manufacturing said multi junction photovoltaic device is disclosed. The metal oxynitride is preferably titanium oxynitride. Advantageously, the device may be produced in a simple, fast, consistent and inexpensive manner, whilst the properties of the titanium oxynitride layer may be tuned to avoid the occurrence of local shunt paths and to reduce reflection losses.

Abstract: There is provided a multi-junction photovoltaic device comprising a first sub-cell disposed over a second sub-cell, the first sub-cell comprising a photoactive region comprising a layer of perovskite material and the second sub-cell comprising a silicon heterojunction (SHJ).

Abstract: Compositions comprising a population of oligodendrocyte progenitor cells (OPCs), as well as methods of making and using the same, are provided. In one aspect, a container comprising a composition, where the composition comprises a population of cells comprising a plurality of OPCs, and where the population of cells comprises less than 15% undesirable cell types is provided. In another aspect, the population of cells comprises less than 15% undesirable epithelial lineage cells. In yet another aspect, the population of cells comprises less than 2% K7 positive cells. In an aspect, a population of cells comprising a plurality of oligodendrocyte progenitor cells is capable of forming less than one epithelial cyst per 100,000 cells in a cyst assay is provided. An even further aspect of the present disclosure is a container comprising a composition, where the composition comprising a plurality of oligodendrocyte progenitor cells is useful in treating treat stroke, spinal cord injury, and multiple sclerosis.

Abstract: There is provided a multi-junction photovoltaic device (100) comprising a first sub-cell (110) disposed over a second sub-cell (120), the first sub-cell comprising a photoactive region comprising a layer of perovskite material and the second sub-cell comprising a silicon heterojunction (SHJ).

Abstract: The present invention provides methods for modulating expression of endogenous cellular genes using recombinant zinc finger proteins.

Abstract: Aspects of the disclosure can provide a face recognition method of increased robustness. The face recognition method can include receiving a target face image, initializing a registration and a block analysis of the target face image identifying one or more portions of the target face image for face recognition, informing a user of the registration and the block analysis, receiving one or more instructions from the user for operating on the registration and the block analysis, and identifying the target face image from a plurality of face images based on the registration and the block analysis of the target face image when the registration and the block analysis are approved by the user.

Abstract: The present invention provides methods for modulating expression of endogenous cellular genes using recombinant zinc finger proteins.

Abstract: A prototype biometric identification system is disclosed that indexes a biometric corpus into indexed-corpuses using a set of P prototypes before searching for a probe in a search corpus constructed based on the indexed-corpus. The system may index the biometric corpus based on the prototypes directly or based on prototype-typicality scores.

Abstract: The present invention provides methods for modulating expression of endogenous cellular genes using recombinant zinc finger proteins.

Abstract: A prototype biometric identification system is disclosed that indexes a biometric corpus into indexed-corpuses using a set of P prototypes before searching for a probe in a search corpus constructed based on the indexed-corpus. The system may index the biometric corpus based on the prototypes directly or based on prototype-typicality scores.

Abstract: The present invention provides methods for modulating expression of endogenous cellular genes using recombinant zinc finger proteins.

Abstract: The present invention provides methods for modulating expression of endogenous cellular genes using recombinant zinc finger proteins.

Abstract: The present invention provides methods for altering tumor growth using zinc finger proteins.

Abstract: The present invention provides methods for modulating expression of endogenous cellular genes using recombinant zinc finger proteins.